Interventions for co-occurring addictive and other mental disorders (AMDs)

Addictive Behaviors

Volumn 34, Issue 10, 2009, Pages 838-845

  Kavanagh, David J ^a   Connolly, Jennifer M ^a  

^a QUEENSLAND UNIVERSITY OF TECHNOLOGY   (Australia)

Author keywords

Comorbidity; Mental disorders; Mental health services; Substance related disorders; Treatment

Indexed keywords

ADDICTION; ARTICLE; CIGARETTE SMOKING; COMORBIDITY; ENDEMIC DISEASE; FOLLOW UP; HEALTH CARE ACCESS; HEALTH CARE SYSTEM; HEALTH PRACTITIONER; HIGH RISK POPULATION; HUMAN; MENTAL DISEASE; MENTAL HEALTH SERVICE; MOTIVATION; PREVALENCE; PSYCHOLOGIC ASSESSMENT; PSYCHOTHERAPY; RELAPSE; RESEARCH ETHICS; SKILL; SMOKING CESSATION PROGRAM; SOCIAL SUPPORT;

BEHAVIOR, ADDICTIVE; COMORBIDITY; DELIVERY OF HEALTH CARE; DIAGNOSIS, DUAL (PSYCHIATRY); HEALTH SERVICES ACCESSIBILITY; HEALTH SERVICES NEEDS AND DEMAND; HUMANS; MASS SCREENING; MENTAL DISORDERS; MENTAL HEALTH SERVICES; RISK FACTORS; SUBSTANCE-RELATED DISORDERS;

EID: 67651100747     PISSN: 03064603     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.addbeh.2009.03.005     Document Type: Article

References (81)

1. Andrews G., Hall W., Teesson M., and Henderson S. The mental health of Australians (1999), Department of Health and Aged Care, Canberra
2. Australian Institute of Health and Welfare. 2004 National Drug Strategy Household Survey: First results (2005), AIHW, Canberra
3. Back S.E., Gentilin S., and Brady K.T. Cognitive-behavioral stress management for individuals with substance use disorders: A pilot study. Journal of Nervous and Mental Disease 195 (2007) 662-668
4. Baker A., Richmond R., Haile M., Lewin T.J., Carr V.J., Taylor R.L., Jansons S., and Wilhelm K. A randomized controlled trial of a smoking cessation intervention among people with a psychotic disorder. American Journal of Psychiatry 163 (2006) 1934-1942
5. Barnes T.R., Mutsatsa S.H., Hutton S.B., Watt H.C., and Joyce E.M. Comorbid substance use and age at onset of schizophrenia. British Journal of Psychiatry 188 (2006) 237-242
6. Barrowclough C., Haddock G., Tarrier N., Lewis S.W., Moring J., O'Brien R., et al. Randomized controlled trial of motivational interviewing, cognitive behavior therapy, and family intervention for patients with comorbid schizophrenia and substance use disorders. American Journal of Psychiatry 158 (2001) 1706-1713
7. Bates M.E., Bowden S.C., and Barry D. Neurocognitive impairment associated with alcohol use disorders: Implications for treatment. Experimental and Clinical Psychopharmacology 10 (2002) 193-212
8. Beck A.T., Wright F.D., Newman C.F., and Liese B.S. Cognitive therapy of substance abuse (1993), Guilford, New York
9. Bellack A., Bennett M.E., Gearon J.S., Brown C.H., and Yang Y. A randomized clinical trial of a new behavioral treatment for drug abuse in people with severe and persistent mental illness. Archives of General Psychiatry 63 (2006) 426-432
10. Berkson J. Limitations of the application of four-fold tables to hospital data. Biological Bulletin 2 (1949) 47-53
11. Birchwood M., and Spencer E. Early intervention in psychotic relapse. Clinical Psychology Review 21 (2001) 1211-1226
12. Brown S., Inskip H., and Barraclough B. Causes of the excess mortality in schizophrenia. British Journal of Psychiatry 177 (2000) 212-217
13. Brown S.A., and Schuckit M.A. Changes in depression among abstinent alcoholics. Journal of Studies on Alcohol 49 (1988) 412-417
14. Burns L.M., Teesson M., and O'Neil K. The impact of comorbid anxiety and depression on alcohol treatment outcomes. Addiction 100 (2005) 787-796
15. Cacciola J.S., Alterman A.I., Rutherford M.J., McKay J., and Mulvaney F.D. The relationship of psychiatric comorbidity to treatment outcomes in methadone maintained patients. Drug and Alcohol Dependence 61 (2001) 271-280
16. Clark R.E., Ricketts S.K., and McHugo G.J. Legal system involvement and costs for persons in treatment for severe mental illness and substance use disorders. Psychiatric Services 50 (1999) 641-647
17. D'Souza D.C., Gil R.B., Madonick S., Perry E.B., Forselius-Bielen K., Braley G., et al. Enhanced sensitivity to the euphoric effects of alcohol in schizophrenia. Neuropsychopharmacology 31 (2006) 2767-2775
18. de Leon J., Diaz F.J., Josiassen R.C., Cooper T.B., and Simpson G.M. Does clozapine decrease smoking?. Progress in Neuro-Psychopharmacology and Biological Psychiatry 29 (2005) 757-762
19. Deci E.L., Koestner R., and Ryan R.M. A meta-analytic review of experiments examining the effects of extrinsic rewards on intrinsic motivation. Psychological Bulletin 125 (1999) 627-668
20. Dixon L., McNary S., and Lehman A. Substance abuse and family relationships of persons with severe mental illness. American Journal of Psychiatry 152 (1995) 456-458
21. Dixon L., Postrado L., Delahanty J., Fischer P.J., and Lehman A. The association of medical comorbidity in schizophrenia with poor physical and mental health. Journal of Nervous and Mental Disease 187 (1999) 496-502
22. Donald M., Dower J., and Kavanagh D.J. Integrated versus non-integrated management and care for clients with co-occurring mental health and substance use disorders: A qualitative systematic review of randomised controlled trials. Social Science and Medicine 60 (2005) 1371-1383
23. Drake R.E., Bartels S.B., Teague G.B., Noordsy D.L., and Clark R.E. Treatment of substance abuse in severely mentally ill patients. Journal of Nervous and Mental Disease 181 (1993) 606-611
24. Drake R.E., McHugo G.J., Xie H., Fox M., Packard J., and Helmstetter B. Ten-year recovery outcomes for clients with co-occurring schizophrenia and substance use disorders. Schizophrenia Bulletin 32 (2006) 464-473
25. Drake R.E., Mueser K.T., Clark R.E., and Wallach M. The natural history of substance disorder in persons with severe mental illness. American Journal of Orthopsychiatry 66 (1996) 42-51
26. Drake R.E., O'Neal E., and Wallach M.A. A systematic review of research on interventions for people with co-occurring severe mental and substance use disorders. Journal of Substance Abuse Treatment 34 (2008) 123-138
27. Gallagher S.M., Penn P.E., Schindler E., and Layne W. A comparison of smoking cessation treatments for persons with schizophrenia and other serious mental illnesses. Journal of Psychoactive Drugs 39 (2007) 487-497
28. George T.P., Vessicchio J.C., Sacco K.A., Weinberger A.H., Dudas M.M., Allen T.M., Creeden C.L., Potenza M.N., Feingold A., and Jatlow P.I. A placebo-controlled trial of bupropion combined with nicotine patch for smoking cessation in schizophrenia. Biological Psychiatry 63 (2008) 1092-1096
29. Gershon G.R.B., Hwang S., Han J., George T., and Brody A.I. Short-term naturalistic outcomes in cigarette smokers with substance abuse and/or mental illness. Journal of Clinical Psychiatry 68 (2007) 892-898
30. Glynn S.M., Cohen A.N., and Niv N. New challenges in family interventions for schizophrenia. Expert Review of Neurotherapeutics 7 (2007) 33-43
31. Green A.I., Noordsy D.L., Brunette M.F., and O'Keefe C. Substance abuse and schizophrenia: pharmacotherapeutic intervention. Journal of Substance Abuse Treatment 34 (2008) 61-71
32. Green B., Kavanagh D.J., and Young R.M. Reasons for cannabis use in men with and without psychosis. Drug and Alcohol Review 23 (2004) 445-453
33. Hall S.M. Nicotine interventions with comorbid populations. American Journal of Preventive Medicine 33 (2007) S406-S413
34. Hides L., Dawe S., Kavanagh D.J., and Young R.M. A prospective study of psychotic symptom and cannabis relapse in recent onset psychosis. British Journal of Psychiatry 189 (2006) 137-143
35. Hirsch S., Bowen J., Emami J., Cramer P., Jolley A., Haw C., et al. A one year prospective study of the effect of life events and medication in the aetiology of schizophrenic relapse. British Journal of Psychiatry 168 (1996) 49-56
36. Hitsman B., Borrelli B., McChargue D.E., Spring B., and Niaura R. History of depression and smoking cessation outcome: A meta-analysis. Journal of Consulting and Clinical Psychology 71 (2003) 657-663
37. Howard J., Stubbs M., and Arcuri A. Comorbidity: Coexisting substance use and mental disorders in young people. Clinical Psychologist 11 (2007) 88-97
38. Jovanovski D., Erb S., and Zakzanis K.K. Neurocognitive deficits in cocaine users: A quantitative review of the evidence. Journal of Clinical and Experimental Neuropsychology 27 (2005) 189-204
39. Kavanagh D.J. Recent developments in expressed emotion and schizophrenia. British Journal of Psychiatry 160 (1992) 601-620
40. Kavanagh D.J., and Bower G.H. Mood and self-efficacy: Impact of joy and sadness on perceived capabilities. Cognitive Therapy and Research 9 (1985) 507-525
41. Kavanagh D.J., Greenaway L., Jenner L., Saunders J.B., White A., Sorban J., et al. Contrasting views and experiences of health professionals on the management of comorbid substance abuse and mental disorders. Australian and New Zealand Journal of Psychiatry 34 (2000) 279-289
42. Kavanagh D.J., McGrath J., Saunders J.B., Dore G., and Clark D. Substance abuse in patients with schizophrenia: Epidemiology and management. Drugs 62 (2001) 743-755
43. Kavanagh, D. J., & Mueser, K. T., (in press). The treatment of substance misuse in people with serious mental disorders. In D. Turkington, R. Hagen, T. Berge & R.W. Gråwe (Eds.), The CBT treatment of psychosis - a symptomatic approach. London Routledge.
44. Kavanagh D.J., Sitharthan G., Young R.M., Sitharthan T., Saunders J.B., Shockley N., et al. Addition of cue exposure to cognitive-behaviour therapy for alcohol misuse: A randomized controlled trial with dysphoric drinkers. Addiction 101 (2006) 1106-1116
45. Kavanagh D.J., Waghorn G., Jenner L., Chant D.C., Carr V., Evans M., et al. Demographic and clinical correlates of comorbid substance use disorders in psychosis: multivariate analyses from an epidemiological sample. Schizophrenia Research 66 (2004) 115-124
46. Kavanagh D.J., Young R., White A., Saunders J.B., Wallis G., Shockley N., et al. A brief intervention for substance abuse in early psychosis. Drug and Alcohol Review 23 (2004) 151-155
47. Kay-Lambkin F.J., Baker A., and Lewin L. The "co-morbidity roundabout": A framework to guide assessment and intervention strategies and engineer change among people with co-morbid problems. Drug and Alcohol Review 23 (2004) 407-423
48. Kessler R.C., Nelson C.B., McGonagle K.A., Edlund M.J., Frank R.G., and Leaf P.J. The epidemiology of co-occurring addictive and mental disorders: Implications for prevention and service utilization. American Journal of Orthopsychiatry 66 (1996) 17-31
49. Kessler R.C., Sonnega A., Bromet E., and Nelson C.B. Posttraumatic stress disorder in the National Comorbidity Survey. Archives of General Psychiatry 52 (1995) 1048-1060
50. Khlat M., Sermet C., and Pape A.L. Increased prevalence of depression, smoking, heavy drinking and use of psycho-active drugs among unemployed men in France. European Journal of Epidemiology 19 (2004) 445-451
51. Kim E.Y., Miklowitz D.J., Biuckians A., and Mullen K. Life stress and the course of early-onset bipolar disorder. Journal of Affective Disorders 99 (2007) 37-44
52. Kodl M.M., Fu S.S., Willenbring M.L., Gravely A., Nelson D.B., and Joseph A.M. The impact of depressive symptoms on alcohol and cigarette consumption following treatment for alcohol and nicotine dependence. Alcoholism: Clinical and Experimental Research 32 (2008) 92-99
53. Kranzler H.R., Mueller T., Cornelius J., Pettinati H.M., Moak D., Martin P.R., et al. Sertraline treatment of co-occurring alcohol dependence and major depression. Journal of Clinical Psychopharmacology 26 (2006) 13-20
54. Levin F.R., Bisaga A., Raby W., Aharonovich E., Rubin E., Mariani J., et al. Effects of major depressive disorder and attention-deficit/hyperactivity disorder on the outcome of treatment for cocaine dependence. Journal of Substance Abuse Treatment 34 (2008) 80-89
55. Martino S., Carroll K.M., Kostas D., Perkins J., and Rounsaville B.J. Dual diagnosis interviewing: A modification of motivational interviewing for substance-abusing patients with psychotic disorders. Journal of Substance Abuse Treatment 23 (2002) 297-308
56. McEvoy J.P., Freudenreich O., and Wilson W.H. Smoking and therapeutic response to clozapine in patients with schizophrenia. Biological Psychiatry 46 (1999) 125-129
57. Merlotti E., Piegari G., and Galderisi S. Cognitive impairment as a core feature of schizophrenia. Minerva Psichiatrica 46 (2005) 67-77
58. Miller W.R., and Rollnick S. Motivational interviewing: Preparing people to change addictive behavior (1991), Guilford Press, New York
59. In: Miller W.R., and Rollnick S. (Eds). Motivational interviewing: Preparing people for change. 2nd ed. (2002), Guilford, New York
60. Mills K.L., Teesson M., Ross J., and Darke S. The impact of post-traumatic stress disorder on treatment outcomes for heroin dependence. Addiction 102 (2007) 447-454
61. In: Minkoff K., and Drake R.E. (Eds). Dual diagnosis of major mental illness and substance disorder Vol. 50 (1991), Jossey-Bass, San Francisco
62. Mueser K.T., Crocker A.G., Frisman L.B., Drake R.E., and Covell N.H. Conduct disorder and antisocial personality disorder in persons with severe psychiatric and substance use disorders. Schizophrenia Bulletin 32 (2006) 626-636
63. Mueser K.T., Drake R.E., and Wallach M. Dual diagnosis: A review of etiological theories. Addictive Behaviors 23 (1998) 717-734
64. Mueser K.T., Goodman L.B., Trumbetta S.L., Rosenberg S.D., Osher F.C., Vidaver R., et al. Trauma and posttraumatic stress disorder in severe mental illness. Journal of Consulting and Clinical Psychology 66 (1998) 493-499
65. Mueser K.T., Kavanagh D.J., and Brunette M.F. Implications of research on comorbidity for the nature and management of substance misuse. In: Miller P.M., and Kavanagh D.J. (Eds). Translation of addictions science into practice: Update and future directions (2007), Elsevier, Oxford 277-320
66. Mueser K.T., Kavanagh D.J., and Brunette M.F. Implications of research on comorbidity for the nature and management of substance misuse. In: Miller P.M., and Kavanagh D.J. (Eds). Translation of addictions science into practice: Update and future directions (2007), Elsevier, Oxford 277-320
67. Potvin S., Pampoulova T., Lipp O., Ait Bentaleb L., Lalonde P., Stip E., et al. Working memory and depressive symptoms in patients with schizophrenia and substance use disorders. Cognitive Neuropsychiatry 13 (2008) 357-366
68. Potvin S., Sepehry A.A., and Stip E. Meta-analysis of depressive symptoms in dual-diagnosis schizophrenia. Australian and New Zealand Journal of Psychiatry 41 (2007) 792-799
69. Pourmand D., Kavanagh D.J., and Vaughan K. Expressed emotion as predictor of relapse in patients with comorbid psychoses and substance use disorder. Australian and New Zealand Journal of Psychiatry 39 (2005) 473-478
70. Prochaska J.J., Delucchi K., and Hall S.M. A meta-analysis of smoking cessation interventions with individuals in substance abuse treatment or recovery. Journal of Consulting and Clinical Psychology 72 (2004) 1144-1156
71. Regier D.A., Farmer M.E., Rae D.S., Locke B.Z., Keith S.J., Judd L.L., et al. Comorbidity of mental disorders with alcohol and other drug abuse. Results from the epidemiologic catchment area (ECA) study. Journal of the American Medical Association 264 (1990) 2511-2518
72. Ridgely M.S., Goldman H.H., and Willenbring M.L. Barriers to the care of persons with dual diagnoses: Organizational and financing issues. Schizophrenia Bulletin 16 (1990) 123-132
73. Ross H.E., Glaser F.B., and Germanson T. The prevalence of psychiatric disorders in patients with alcohol or other drug problems. Archives of General Psychiatry 45 (1988) 1023-1031
74. Salyers M.P., and Mueser K.T. Social functioning, psychopathology, and medication side effects in relation to substance use and abuse in schizophrenia. Schizophrenia Research 48 (2001) 109-123
75. Schuckit M.A., Tipp J.E., Bergman M., Reich W., Hesselbrock V.M., and Smith T.L. Comparison of induced and independent major depressive disorders in 2945 alcoholics. American Journal of Psychiatry 154 (1997) 948-957
76. Scurlock H., and Lucas P. Another case of nicotine psychosis?. Addiction 91 (1996) 1388
77. Sigmon S.C., and Higgins S.T. Voucher-based contingent reinforcement of marijuana abstinence among individuals with serious mental illness. Journal of Substance Abuse Treatment 30 (2006) 291-295
78. Sinha R. How does stress increase risk of drug abuse and relapse?. Psychopharmacology 158 (2001) 343-359
79. Teesson M., Hall W., Lynskey M., and Degenhardt L. Alcohol- and drug-use disorders in Australia: Implications of the National Survey of Mental Health and Wellbeing. Australian and New Zealand Journal of Psychiatry 34 (2000) 206-213
80. Tiet Q.Q., and Mausbach B. Treatments for patients with dual diagnosis: A review. Alcoholism: Clinical and Experimental Research 31 (2007) 513-536
81. Zakzanis K.K., Leach L., and Kaplan E. On the nature and pattern of neurocognitive function in major depressive disorder. Neuropsychiatry, Neuropsychology, and Behavioral Neurology 11 (1998) 111-119